A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent

[1] Villa LL(2005)Prophylactic human papillomavirus (types 6,11,16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6 271-8

[2] Costa RR(2005)The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management Eur J Gynaecol Oncol XXVI 129-142

[3] Petta CA(2006)HPV vaccine introduction in industrialized countries Vaccine 24 S178-86

[4] Andrade R(2004)Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Lancet 364 1757-65

[5] Ault K(2006)Prophylactic HPV vaccines: underlying mechanisms Vaccine 24 106-13

[6] Giuliano A(2006)Modelling the impact of HPV vaccines on cervical cancer and screening programmes Vaccine 24 S178-86

[7] Wheeler C(2006)Psychosocial aspects of vaccine acceptability Vaccine 24 S201-209

[8] Koutsky L(2006)Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes Vaccine 24 3087-94

[9] Malm C(2001)Sexual behaviour in Britain: early heterosexual experience Lancet 357 1843-50

[10] Lehtinen M(2005)Informed consent: is it sacrosanct? Research Ethics Rev 1 77-83

[1] Villa LL(2005)Prophylactic human papillomavirus (types 6,11,16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6 271-8

[2] Costa RR(2005)The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management Eur J Gynaecol Oncol XXVI 129-142

[3] Petta CA(2006)HPV vaccine introduction in industrialized countries Vaccine 24 S178-86

[4] Andrade R(2004)Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Lancet 364 1757-65

[5] Ault K(2006)Prophylactic HPV vaccines: underlying mechanisms Vaccine 24 106-13

[6] Giuliano A(2006)Modelling the impact of HPV vaccines on cervical cancer and screening programmes Vaccine 24 S178-86

[7] Wheeler C(2006)Psychosocial aspects of vaccine acceptability Vaccine 24 S201-209

[8] Koutsky L(2006)Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes Vaccine 24 3087-94

[9] Malm C(2001)Sexual behaviour in Britain: early heterosexual experience Lancet 357 1843-50

[10] Lehtinen M(2005)Informed consent: is it sacrosanct? Research Ethics Rev 1 77-83